fda ends tirzepatide shortage Is No Longer On FDA's List: Implications for Healthcare Practices and Compounding Pharmacies FDA says tirzepatide shortage is

Direct Comparison: Real-World Weight Loss Examples: 250-Pound Person: With Tirzepatide (Mounjaro/Zepbound/Compounded): Average loss: 50-56 pounds Final weight: 194-200 pounds Timeline: 16-20 months With Semaglutide (Wegovy/Ozempic/Compounded): Average loss: 37 pounds Final weight: 213 pounds Timeline: 16-18 months 200-Pound Person: With Tirzepatide: Average loss: 40-45 pounds Final weight: 155-160 pounds Timeline: 16-20 months With Semaglutide: Average loss: 30 pounds Final weight: 170 pounds Timeline: 16-18 months Brand vs Compounded Effectiveness: Common Question: Is compounded as effective as brand-name? Short Answer: Yes, when properly compounded

As you build muscle , your metabolism will catch up

Value of GLP-1 receptor agonists versus long-acting insulins for type 2 diabetes patients with and without established cardiovascular or chronic kidney diseases: a model-based cost-effectiveness analysis using real-world data

doi: 10.1542/peds.2013-2336 49

Improved Metabolic Health : Besides weight loss, the treatment can improve various metabolic markers, like blood sugar levels, in people with type 2 diabetes